Y-90 Radioembolization Plus Pembrolizumab Generates Early Efficacy Signals in HCC
Matthew S. Johnson, MD, discusses a pilot study of Y-90 radioembolization plus pembrolizumab in patients with poor-prognosis hepatocellular carcinoma.
Stay updated with breaking news from Matthews Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Matthew S. Johnson, MD, discusses a pilot study of Y-90 radioembolization plus pembrolizumab in patients with poor-prognosis hepatocellular carcinoma.
Former clerks of Justice Sandra Day O’Connor reflect on her pragmatic view of the law, her lessons on living a full life, and her modeling of excellence, strength, and kindness.
THURSDAY, March 16, 2023 (HealthDay News) -- Inferior vena cava filters (VCFs) are a safe and effective way to treat venous thromboembolism (VTE), according to a study published online Feb. 23 in the Journal of Vascular and Interventional Radiology. Matthew S. Johnson, M.D., from Indiana University School of Medicine in Indianapolis, and colleagues assessed the
Justice Department officials have launched an investigation into the bank amid growing questions about who shares responsibility for the largest bank failure since the 2008 collapse.
Justice Department officials have launched an investigation into the bank amid growing questions about who shares responsibility for the largest bank failure since the 2008 collapse.